Janine N. Copp
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Correction: The biosynthesis of N-acyalated tryptazolone in Mycobacterium tuberculosis and related bacteria.
Journal: The Journal of biological chemistry
Published: March 08, 2026
The biosynthesis of N-acylated tryptazolone in Mycobacterium tuberculosis and related bacteria.
Journal: The Journal of biological chemistry
Published: November 10, 2025
Expanding the biocatalytic and oxidative landscape of the old yellow enzyme family.
Journal: Protein science : a publication of the Protein Society
Published: August 01, 2025
From Binding to Catalysis: Emergence of a Rudimentary Enzyme Conferring Intrinsic Antibiotic Resistance.
Journal: Molecular biology and evolution
Published: January 27, 2025
Deciphering the biosynthesis of a novel lipid in Mycobacterium tuberculosis expands the known roles of the nitroreductase superfamily.
Journal: The Journal of biological chemistry
Published: April 27, 2023
A metagenomic library cloning strategy that promotes high-level expression of captured genes to enable efficient functional screening.
Journal: bioRxiv : the preprint server for biology
Published: March 30, 2023
A metagenomic library cloning strategy that promotes high-level expression of captured genes to enable efficient functional screening.
Journal: Cell chemical biology
Published: March 24, 2023
A conserved SH3-like fold in diverse putative proteins tetramerizes into an oxidoreductase providing an antimicrobial resistance phenotype.
Journal: Philosophical transactions of the Royal Society of London. Series B, Biological sciences
Published: January 12, 2023
Discovery of Highly Trimethoprim-Resistant DfrB Dihydrofolate Reductases in Diverse Environmental Settings Suggests an Evolutionary Advantage Unrelated to Antibiotic Resistance.
Journal: Antibiotics (Basel, Switzerland)
Published: November 22, 2022
Interrogation of the Structure-Activity Relationship of a Lipophilic Nitroaromatic Prodrug Series Designed for Cancer Gene Therapy Applications.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 16, 2021
Last Updated: 09/26/2026